Test ID CIDP Chronic Inflammatory Demyelinating Polyradiculoneuropathy/Nodopathy Evaluation, Serum
Ordering Guidance
Multiple neurological phenotype-specific autoimmune/paraneoplastic evaluations are available. For more information as well as phenotype-specific testing options, refer to Autoimmune Neurology Test Ordering Guide.
For a list of antibodies performed with each evaluation, see Autoimmune Neurology Antibody Matrix.
Specimen Required
Patient Preparation: For optimal antibody detection, it is recommended collecting the specimen before initiation of immunosuppressant medication.
Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 3 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Forms
If not ordering electronically, complete, print, and send a Neurology Specialty Testing Client Test Request (T732) with the specimen.
Useful For
Evaluating for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and related demyelinating peripheral neuropathies
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
CIDPI | CIDP/NP Interpretation, S | No | Yes |
CONCS | Contactin-1 IgG CBA, S | No | Yes |
NF4FS | Neurofascin-155 IgG4, S | No | Yes |
Method Name
CONCS: Cell Binding Assay (CBA)
NF4FS: Flow Cytometry (FCM)
CIDPI: Medical Interpretation
Reporting Name
CIDP/NP Evaluation, SSpecimen Type
SerumSpecimen Minimum Volume
2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Reference Values
Contactin-1 IgG: Negative
Neurofascin-155 IgG4: Negative
Day(s) Performed
CONCS: Monday through Thursday, Sunday
NF4FS: Monday, Friday
Report Available
5 to 10 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
86255 x 2
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CIDP | CIDP/NP Evaluation, S | 101447-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
614591 | Neurofascin-155 IgG4, S | 100845-7 |
616444 | CIDP/NP Interpretation, S | 69048-7 |
616442 | Contactin-1 IgG CBA, S | 101448-9 |